Back to EPRX

INGALLS & SNYDER LLC → EPRX

INGALLS & SNYDER LLC EPRX Position History

Eupraxia Pharmaceuticals Inc. • Healthcare

Quarters held
4
Latest value
$687K
Q3 2026
Peak value
$687K
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$584K
Q1 2026$548K
Q2 2026$452K
Q3 2026$687K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$687K75.5K——
Q2 2026$452K68.5K——
Q1 2026$548K75.7K——
Q4 2025$584K77.4K——

Other funds holding EPRX

Other INGALLS & SNYDER LLC positions

CORT

CORCEPT THERAPEUTICS INC

$883.6M
CORT

CORCEPT THERAPEUTICS INC

$689.9M
CORT

CORCEPT THERAPEUTICS INC

$306.7M
OGC

OCEANAGOLD CORP

$274.7M
OGC

OCEANAGOLD CORP

$251.9M
CORT

CORCEPT THERAPEUTICS INC

$250.4M
XOM

EXXON MOBIL CORP

$115.3M
CNQ

CANADIAN NAT RES LTD MED TER

$113.9M